Qiang Zuo
- Cancer Research top 10%
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
- HER2/EGFR in Cancer Research 3
-
- PI3K/AKT/mTOR signaling in cancer 8
- Melanoma and MAPK Pathways 3
- Extracellular vesicles in disease 3
-
- Cancer Mechanisms and Therapy 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Lihong GuoMengwan WuWangjun LiaoMin ShiJing GuoYulin LiaoDayong ZhengLin Li
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Qiang Zuo
34 papers receiving 794 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 200
- Oncology 315
- Molecular Biology 417
- Pathology and Forensic Medicine 100
- Cell Biology 68
Countries citing papers authored by Qiang Zuo
This map shows the geographic impact of Qiang Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Zuo more than expected).
Fields of papers citing papers by Qiang Zuo
This network shows the impact of papers produced by Qiang Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Zuo. The network helps show where Qiang Zuo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiang Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 68 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 30 | |
| 12 | 2018 | 76 | |
| 13 | 2017 | 9 | |
| 14 | 2015 | 51 | |
| 15 | 2015 | 15 | |
| 16 | 2013 | 98 | |
| 17 | 2012 | 26 | |
| 18 | 2011 | 25 | |
| 19 | 2011 | 9 | |
| 20 | 2010 | 12 |
About Qiang Zuo
Qiang Zuo is a scholar working on Pathology and Forensic Medicine, Otorhinolaryngology and Oncology, having authored 39 papers that have together received 805 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Mechanisms and Therapy (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Peptidase Inhibition and Analysis (4 papers), Melanoma and MAPK Pathways (3 papers), HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (200 citations), Oncology (315 citations) and Molecular Biology (417 citations). Qiang Zuo has collaborated with scholars based in China and United States. Frequent co-authors include Lihong Guo, Mengwan Wu, Wangjun Liao, Min Shi, Jing Guo, Yulin Liao, Dayong Zheng, Lin Li, Li Sun and Jing Guo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.